Targeting Leukocyte Traffic: A New Era for the Treatment of Inflammatory Bowel Disease

Overview

Journal J Crohns Colitis

Publisher Oxford University Press

Date 2018 Aug 24

PMID 30137310

Citations 1

Authors

Jesus Rivera-Nieves

Affiliations

Soon will be listed here.

Citing Articles

Sphingosine-1-Phosphate Lyase Inhibition Alters the S1P Gradient and Ameliorates Crohn's-Like Ileitis by Suppressing Thymocyte Maturation.

Karuppuchamy T, Tyler C, Lundborg L, Perez-Jeldres T, Kimball A, Clambey E Inflamm Bowel Dis. 2019; 26(2):216-228.

PMID: 31807751 PMC: 6943703. DOI: 10.1093/ibd/izz174.

References

Holzmann B, McIntyre B, Weissman I . Identification of a murine Peyer's patch--specific lymphocyte homing receptor as an integrin molecule with an alpha chain homologous to human VLA-4 alpha. Cell. 1989; 56(1):37-46. DOI: 10.1016/0092-8674(89)90981-1. View

Danese S, Furfaro F, Vetrano S . Targeting S1P in Inflammatory Bowel Disease: New Avenues for Modulating Intestinal Leukocyte Migration. J Crohns Colitis. 2017; 12(suppl_2):S678-S686. DOI: 10.1093/ecco-jcc/jjx107. View

Gallatin W, Weissman I, Butcher E . A cell-surface molecule involved in organ-specific homing of lymphocytes. Nature. 1983; 304(5921):30-4. DOI: 10.1038/304030a0. View

Trivedi P, Adams D . Chemokines and Chemokine Receptors as Therapeutic Targets in Inflammatory Bowel Disease; Pitfalls and Promise. J Crohns Colitis. 2018; 12(suppl_2):S641-S652. PMC: 6104621. DOI: 10.1093/ecco-jcc/jjx145. View

Butcher E, Scollay R, Weissman I . Organ specificity of lymphocyte migration: mediation by highly selective lymphocyte interaction with organ-specific determinants on high endothelial venules. Eur J Immunol. 1980; 10(7):556-61. DOI: 10.1002/eji.1830100713. View

Lamb C, OByrne S, Keir M, Butcher E . Gut-Selective Integrin-Targeted Therapies for Inflammatory Bowel Disease. J Crohns Colitis. 2018; 12(suppl_2):S653-S668. DOI: 10.1093/ecco-jcc/jjy060. View

Weissman I . Lymphocytes, Jim Gowans and in vivo veritas. Nat Immunol. 2010; 11(12):1073-5. DOI: 10.1038/ni1210-1073. View

Panes J, Salas A . Past, Present and Future of Therapeutic Interventions Targeting Leukocyte Trafficking in Inflammatory Bowel Disease. J Crohns Colitis. 2018; 12(suppl_2):S633-S640. DOI: 10.1093/ecco-jcc/jjy011. View

Gowans J . The recirculation of lymphocytes from blood to lymph in the rat. J Physiol. 1959; 146(1):54-69. PMC: 1356889. DOI: 10.1113/jphysiol.1959.sp006177. View

10.

Reinisch W, Hung K, Hassan-Zahraee M, Cataldi F . Targeting Endothelial Ligands: ICAM-1/alicaforsen, MAdCAM-1. J Crohns Colitis. 2018; 12(suppl_2):S669-S677. DOI: 10.1093/ecco-jcc/jjy059. View

11.

Gallatin M, St John T, Siegelman M, Reichert R, Butcher E, Weissman I . Lymphocyte homing receptors. Cell. 1986; 44(5):673-80. DOI: 10.1016/0092-8674(86)90832-9. View

12.

SIEGELMAN M, van de Rijn M, Weissman I . Mouse lymph node homing receptor cDNA clone encodes a glycoprotein revealing tandem interaction domains. Science. 1989; 243(4895):1165-72. DOI: 10.1126/science.2646713. View

13.

Derkx B, Taminiau J, Radema S, Stronkhorst A, Wortel C, Tytgat G . Tumour-necrosis-factor antibody treatment in Crohn's disease. Lancet. 1993; 342(8864):173-4. DOI: 10.1016/0140-6736(93)91375-v. View

14.

Targan S, Hanauer S, van Deventer S, Mayer L, Present D, Braakman T . A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group. N Engl J Med. 1997; 337(15):1029-35. DOI: 10.1056/NEJM199710093371502. View